Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (R/R B-NHL)
1 clinical trials · Condition
◉ Watch Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (R/R B-NHL)
| Record | Firm | Date |
|---|---|---|
| Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NCT07345741) | Donghua Zhang | 2025-12-31 |
Track Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (R/R B-NHL) automatically
Every clearance here is in the API, with alerts when new ones post.